Cargando…
New Engineered-Botulinum Toxins Inhibit the Release of Pain-Related Mediators
Targeted delivery of potent inhibitor of cytokine/pain-mediator into inflammatory or pain-sensing cells is a promising avenue for treating chronic pain, a world-wide major healthcare burden. An unmet need exists for a specific and effective delivery strategy. Herein, we describe a new approach using...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981458/ https://www.ncbi.nlm.nih.gov/pubmed/31906003 http://dx.doi.org/10.3390/ijms21010262 |